Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
+0.010 (0.88%)
Feb 17, 2026, 10:03 AM EST - Market open
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $25.52 million as of February 17, 2026. Its market cap has decreased by -53.10% in one year.
Market Cap
25.52M
Enterprise Value
-42.52M
1-Year Change
-53.10%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $25.52M, a decrease of -92.83%. That is a compound annual growth rate of -75.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 25.29M | -5.83% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 27.52M |
| IO Biotech | 26.59M |
| Lixte Biotechnology Holdings | 26.57M |
| Exicure | 26.01M |
| Barinthus Biotherapeutics | 25.68M |
| Rallybio | 25.45M |
| AEON Biopharma | 25.30M |
| IGC Pharma | 24.53M |